Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Nantahala Capital Management, LLC | 3,974,326 9.990% |
2,059,200 (+107.52%) |
Filing History |
| 2025-02-13 12:07 pm Sale |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Stonepine Capital Management, LLC | 2,353,099 6.000% |
-478,740 (-16.91%) |
Filing History |
| 2025-02-12 3:54 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
SILVERARC CAPITAL MANAGEMENT LLC | 3,065,649 7.800% |
3,065,649 (New Position) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
HIRSCHMAN ORIN | 2,662,785 6.800% |
1,284,840 (+93.24%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | TELA Bio, Inc. TELA |
Nantahala Capital Management, LLC | 1,915,126 7.749% |
1,915,126 (New Position) |
Filing History |
| 2024-11-14 1:06 pm Purchase |
2024-09-30 | 13G | TELA Bio, Inc. TELA |
LYTTON LAURENCE W | 2,452,257 9.900% |
1,112,205 (+83.00%) |
Filing History |
| 2024-10-29 5:12 pm Purchase |
2024-10-23 | 13G | TELA Bio, Inc. TELA |
Stonepine Capital Management, LLC | 2,831,839 7.700% |
2,831,839 (New Position) |
Filing History |
| 2024-10-28 4:06 pm Unchanged |
2024-10-24 | 13G | TELA Bio, Inc. TELA |
EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 10.440% |
0 (Unchanged) |
Filing History |
| 2024-10-25 4:24 pm Sale |
2024-10-23 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 1,182,717 4.800% |
-941,550 (-44.32%) |
Filing History |
| 2024-10-01 5:35 pm Sale |
2024-09-27 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,124,267 8.600% |
-313,700 (-12.87%) |
Filing History |
| 2024-07-30 5:50 pm Purchase |
2024-07-24 | 13G | TELA Bio, Inc. TELA |
GROW FUNDS, LLC. | 1,402,017 5.700% |
1,402,017 (New Position) |
Filing History |
| 2024-07-22 3:20 pm Purchase |
2024-07-10 | 13G | TELA Bio, Inc. TELA |
LYTTON LAURENCE W | 1,340,052 5.400% |
1,340,052 (New Position) |
Filing History |
| 2024-07-02 4:58 pm Sale |
2024-06-28 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,437,967 9.900% |
-428,300 (-14.94%) |
Filing History |
| 2024-06-10 09:00 am Sale |
2024-05-31 | 13G | TELA Bio, Inc. TELA |
First Light Asset Management, LLC | 0 0.000% |
-2,723,028 (Position Closed) |
Filing History |
| 2024-02-14 5:23 pm Purchase |
2023-12-31 | 13G | TELA Bio, Inc. TELA |
First Light Asset Management, LLC | 2,723,028 11.120% |
194,428 (+7.69%) |
Filing History |
| 2024-02-14 06:35 am Purchase |
2023-12-31 | 13G | TELA Bio, Inc. TELA |
EW HEALTHCARE PARTNERS FUND 2 L.P. | 4,110,709 16.790% |
5,000 (+0.12%) |
Filing History |
| 2024-02-07 6:55 pm Sale |
2023-12-31 | 13G | TELA Bio, Inc. TELA |
HIRSCHMAN ORIN | 1,377,945 5.600% |
-301,336 (-17.94%) |
Filing History |
| 2023-10-06 11:47 am Purchase |
2023-09-30 | 13G | TELA Bio, Inc. TELA |
First Light Asset Management, LLC | 2,528,600 10.330% |
2,528,600 (New Position) |
Filing History |
| 2023-04-21 5:03 pm Sale |
2023-04-19 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,866,267 11.900% |
-192,000 (-6.28%) |
Filing History |
| 2023-02-15 06:56 am Purchase |
2022-12-31 | 13G | TELA Bio, Inc. TELA |
HIRSCHMAN ORIN | 1,679,281 8.700% |
161,289 (+10.63%) |
Filing History |